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Abstract. Phagocytosis by monocytes or neutrophils 
can be enhanced by interaction with several proteins 
or synthetic peptides containing  the Arg-Gly-Asp se- 
quence.  Recently we showed that an mAb, B6H12, 
specifically inhibited this enhancement of neutrophil 
phagocytosis by inhibiting  Arg-Gly-Asp binding to the 
leukocyte response integrin (Gresham,  H. D., J.  L. 
Goodwin, P. M.  Allen,  D.  C.  Anderson,  and E. J. 
Brown.  1989.  £  Cell Biol.  108:1935-1943).  Now, we 
have purified the antigen recognized by B6H12 to 
homogeneity. Surprisingly,  it is a 50-kD molecule that 
is expressed on the plasma membranes of all hema- 
topoietic cells, including erythrocytes, which express 
no known integrins.  On platelets and placenta,  but not 
on erythrocytes, this protein is associated with an inte- 
grin that can be recognized by an anti-B3 antibody. In 
addition,  both the anti-B3 and several mAbs recogniz- 
ing the 50-kD protein inhibit Arg-Gly-Asp stimulation 
of phagocytosis. These data demonstrate an associa- 
tion between integrins  and the 50-kD protein on sev- 
eral cell types. For this reason,  we call it Integrin- 
associated Protein (LAP). We hypothesize that LAP 
may play a role in signal transduction for enhanced 
phagocytosis by Arg-Gly-Asp ligands. 
p 
HAGOCYTOSIS is a regulated  function in professional 
phagocytes. Unstimulated phagocytes show decreased 
capacity for ingestion compared with cells stimulated 
with a variety of cytokines, phorbol esters, or extracellular 
matrix  (ECM) 1 proteins (Pommier et al.,  1983, 1984a,b; 
Wright et al., 1983; Bohnsack et al., 1985; Gresham et al., 
1988; Graham et al.,  1989). The ECM-phagocyte interac- 
tion may be proinflammatory for other functions  as well, 
such as printing for an enhanced, prolonged respiratory burst 
(Nathan et al., 1989) or inducing degranulation  (Wachtfogel 
et al.,  1988). We have hypothesized that the interaction  of 
ECM with phagocytes provides a signal that the cells have 
moved out of the vasculature  and into an area of inflamma- 
tion or infection (Brown,  1986). Subsequent work has shown 
that  at least some of the effects of the ECM are mediated 
through  recognition  of the Arg-Gly-Asp (RGD) sequence in 
ECM proteins by phagocyte integrin  receptors (Wright and 
Meyer,  1985;  Brown and Goodwin,  1988).  Our previous 
work suggested that a heterodimer on PMN and monocytes 
that bound to RGD-Sepharose was a prime candidate  for the 
integrin receptor through which ECM enhanced the phago- 
cytic function of these cells (Brown  and Goodwin,  1988; 
Gresham et al., 1989). This heterodimer had characteristics 
which suggested that it was related to the B3 integrin family. 
1.  Abbreviations  used in  this  paper:  ECM,  extracellular matrix;  fmoe, 
9-fluorenylmethyloxycarbonyl,  IAP, integrin-associated protein; LRI, leu- 
kocyte response integrin; NPGB, paranitrophenyl pmaaguanidinobenzoate. 
Because it mediated phagocytic  responses to several RGD- 
containing  proteins,  we termed this receptor the Leukocyte 
Response Integrin  (LRI). 
Recently, we described an mAb, B6H12, that inhibited the 
RGD-dependent enhancement  of neutrophil  IgG-mediated 
phagocytosis (Gresham et al.,  1989).  This  mAb inhibited 
phagocytosis enhancement  by fibronectin,  collagen type IV, 
von WiUebrand's factor,  fibrinogen,  and vitronectin  as well 
as by synthetic RGD-containing  ligands, but had no effect on 
laminin-enhanced  phagocytosis.  Because B6H12 was able to 
inhibit RGD-dependent binding of the synthetic ligands and 
immunoprecipitated  a PMN receptor similar in behavior on 
SDS-PAGE  the  heterodimer  we  had  purified  on  RGD- 
Sepharose,  we hypothesized that it recognized LRI, the cell 
surface integrin  involved in phagocytosis enhancement. 
Here we report that the antigen  recognized by B6H12 is 
not an integrin but a 50-kD protein functionally and perhaps 
physically  associated with LRI. The antigen  is widely dis- 
tributed, including expression on erythrocytes, a cell with no 
known  integrins.  Using  immunoprecipitation  and  affinity 
purification  of the 50-kD protein with B6HI2 antibody,  an 
associated integrin  was found in platelets  and placenta, but 
not in erythrocytes. As we had shown for LRI (Gresham et 
al., 1989), the associated integrin B had immunologic char- 
acteristics consistent with B3. In addition,  mAb recognizing 
both  the  50-kD  protein  and  /33  inhibited  Arg-Gly-Asp- 
stimulated  ingestion  by both PMN and monocytes. These 
data show that the 50-kD protein can modulate LRI function 
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reason,  we  have called  this  membrane  protein,  Integrin- 
associated Protein (LAP). We postulate that LAP is part ofthe 
signal transduction mechanism for some ECM-integrin in- 
teractions.  Because LAP is expressed on erythrocYtes  in- 
dependently of known integrins, it may also represent a mol- 
ecule involved in signal transduction for other receptors. 
Materials and Methods 
Reagents 
All reagents were obtained as previously described (Gresham et al., 1989). 
B6H12 antibody was obtained as described (Gresham et al., 1989); IgG was 
purified from B6H12 ascites by octanoic acid precipitation (Steinbuch and 
Audran, 1969) and DEAE-Sephacel chromatography.  7132 antibody is an 
IgGl  rnAb which recognizes the integrin ~3 band by Western blot and 
which immunoprecipitates gpHb/IlIa and vitronectin receptor (Gresham et 
ai.,  1989), and which gives a typical staining pattern for t3 on osteoclasts 
and platelets.  B3FI2 (3F12) is a w.Ab that recognizes c~v (Gresham et al., 
1989); 3D9 is a mAb that recognizes complement receptor type I (O'Shea 
et al., 1985); W6/32 is a mAb that recognizes a monomorphic determinant 
on HLA class I, and HYPC  1643 is an antiphosphorylcholine mAb. For 
these mAbs, IgG was obtained from ascites fluid by octanoic acid precipita- 
tion. mAbs IgO were coupled to cyanogen bromide-Sepharose (Pbarmaeia 
Fine Chemicals, Piscataway, NJ) at 5 mg/ml. Fibronectin was purified as 
described (Pommier et al.,  1983). 
Ce//s 
Monocytes (Pommier et al., 1983), PMN (Gresham et al., 1988, 1989), and 
platelets (Brown and Goodwin,  1988) were purified as previously described. 
Erythrocytes were obtained from the dextran sulfate pellet during PMN 
purification, and washed  three times in HBSS.  The myelomonocytic  cell 
lines HL60 and U937 were maintained in Iscove's Medium with 10% FBS. 
Phagocytosis Assays 
Sheep  erythrocytes opsonized  with  either IgG  (EIgG)  or  complement 
(EC3b) were prepared as phagocytic targets as previously  described (Pore- 
mier et al.,  1983).  Fibronectin stimulation of ingestion by  uncultured, 
elntriated peripheral blood monocytes was performed essentially  as de- 
scribed (Pommier et al., 1983) using monoqytes adherent to Labtek cham- 
bers (Miles Scientific,  Naperville, IL), and fibroneetin added in solution 
with target EC3b. Assay of EIgG ingestion by PMN was performed in sus- 
pension, as previously described (Gresham et al., 1988, 1989). Phagocyto- 
sis assays for both PMN and monocytes were performed in the presence of 
catalase (5,000 U/assay;  Sigma Chemical Co., St. Louis, MO) (Gresham 
et al.,  1989). Phagocytosis  was quantitated as a phagocytic  index (PI, no. 
of erythrocytes ingested/100  phagocytes). 
Synthetic Peptide 
In some cases, phagocytosis was stimulated with 5 t~g/ml of a synthetic pep- 
tide  based  on  the  Arg-Gly-Asp  (RGD)  sequence.  This  peptide  was  a 
branched peptide,  prepared  using 9-fluorenylmethyloxycarbonyl  (fmoc) 
chemistry and the Ramps (Dupont) Corp., W'tlmington, DE) system, based 
on the synthetic concept of Posnett et ai. (1988). The peptide was an eightfold 
repeat of GRGDSPA (Fig.  1). We have found that oligomerization of the 
RGD sequence is necessary for RGD-dependent stimulation of phagocytosis. 
Purification of the B6HI2 Antigen 
Placental membranes were  prepared,  solubilized,  incubated with wheat 
germ agglutinin-agerose and with an irrelevant  3,-IFN-affinity column as de- 
scribed (Calderon et al., 1988). The WGA-binding, 7-IFN nonbinding frac- 
tions were pooled and incubated with B6HI2 Sepharose,  which was sequen- 
tially washed with buffer A (150 mM NaCI,  25 mM Hepes,  3 mM Ca  z+, 
1 mM Mg  z+, 25 ltM paranitrophenyl paraguanidinobenzoate (NPGB), 10 
mM CHAPS, pH 7.4) and buffer B (buffer A containing 500 mM NaC1). 
Bound proteins were eluted with buffer E (500 mM NaC1, 100 mM glycine, 
10 mM CHAPS, pH 3.3) and immediately neutralized with 1/10 voi 1 M 
GRGDSPAK~K 
2S222>  \  Figure L Structure of the branched 
peptide used to stimulated PMN 
ingestion  of opsonized  etythrocy~. 
The branched peptide (branched 
RGD) was synthesized according 
to the conception of Posnett et al. 
(1988),  using fmoc chemistry. 
"Iris. After dialysis against buffer A, the eluted proteins were re.applied to 
the B6H12 affinity coluum, washed,  and eluted identically. 
B6H12 antigen was purified from erythrocytes, platelets,  and HLt0 and 
U937 cells following essentially an identical  scheme.  Cells were initially 
solubilized  in a buffer identical  to buffer A, except with 1% Triton X-100 
instead of CHAPS, and containing 20 mM iodoacetamide and 10 pg/ml 
each of leupeptin, pepstatin A, and aprotinin as additional protease inhib- 
itors. 
Tryptic Peptides of  lAP 
100  ttg of purified placental IAP  was  carboxymethylated  as  described 
(Crestfield et al., 1963), diluted to 4x vol to reduce the guanidine concen- 
tration and incubated for 24 h at 37°C  with 5/~g/ml TPCK-trypsin.  The 
reaction was stopped by injection onto a C18 reverse phase HPLC column 
equilibrated with 0.05 % trifluoracetic acid.  Peptides  were elnted with a 
2-80% gradient of acetonitrile. Peptides were sequenced by automated Ed- 
man degradation by the Washington University Protein Chemistry Labora- 
tory.  Each reported peptide sequence was  obtained from two different 
purifications of IAP. Peptide sequences were compared to sequences in the 
National Biomedical  Research Foundation database (version 23) using the 
PSQ programs of the Protein Information Resource. 
Preparation of mAbs 
Mice were immunized with purified antigen from placenta obtained by 
affinity chromatography as above.  The spleen of a single mouse was re- 
moved and single cells were fused with the nonsecreting myeloma cell line 
P3X63AGB.6.5.3. Hybridoma supernatants were screened for antigen reac- 
tivity using an ELISA in which wells were coated with 100 ng of purified 
protein. All cloned hybridoma supernatants used in subsequent experiments 
gave absorbance  values at 490 nm between 1.0 and 1.5. mAbs were screened 
for crossreactivity with B6HI2 by incubating 100 tzl of varying dilutions of 
antibody-containing  tissue culture supernatant together with 200 rig of bio- 
tinylated B6H12 antibody on ELISA wells  coated with purified antigen. 
Bound B6HI2 was detected with avidin-peroxidase  (E-Y Laboratories, San 
Mateo,  CA). 
Immunoprecipitation 
Platelets  were surface radiolabeled as described for erythrocytes (Thomp- 
son et ai.,  1987),  washed three times with HBSS and then solubilized  at 
a concentration of 1-5 x  10~°/ml in a lysis buffer consisting of HBSS with 
20 mM  Hepes,  10 mM  iodoacetamide,  10 mg/ml ovalbumin,  5  t~g/ml 
leupeptin,  10 izg/ml pepstatin A, 10 t~g/ml aprotinin, 50 t~M paranitrophenyl 
paraguanidinobenzoate, and 0.2%  Triton-X 100. After 30 min at 4°C, ly- 
sates were cleared of insoluble material by centrifngation at 15,000 g for 
10 min, and supernatants were cleared of nonspecifically  binding material 
by incubation with gelatin-Sepbarose  overnight at 4oc. Precleared lysates 
were then precipitated by incubation with Sepharose-bound antibodies for 
3 h at room temperature.  The immunoaffinity beads were then washed with 
lysis buffer without ovalbumin four times, and specifically bound material 
was eluted with 0.05 M diethylamine,  0.5% Triton-X 100,  pH 11.3. The elu- 
ate was neutralized with 1/20 eel of 1 M NaH2PO4, and immediately pre- 
pared for SDS-PAGE by incubation with an equal volume of sample buffer 
at 60°C for 15 min. 
For soma experiments,  an octylglucoside  extract of placental proteins 
(Calderon et al.,  1988)  was  labeled with Na1251 using chloroglycoluril 
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B6H12 was purified as described in Materials and Methods, run on 
SDS-PAGE, and silver stained. When prepared for SDS-PAGE at 
60°C, the antigen had an apparent Mr of 50,000 (A). A faint band 
at  100 kD  was also  visible.  When  prepared  for SDS-PAGE at 
100°C, the 100-kD band became much more prominent, and even 
higher apparent molecular mass forms appeared when 50 mM DTT 
was added to the 100°C incubation (B). When a 100°C-incubated 
sample was run on SDS-PAGE (C, pre) and the 50-kD band cut out 
and electroeluted from the gel, it again showed two bands on subse- 
quent SDS-PAGE  (C, post). These data suggest that the B6H12 anti- 
gen is a 50-kD species that aggregates to higher relative molecular 
mass forms at least in part during incubation at elevated tempera- 
tures in SDS-PAGE sample buffer. 
(Markwell and Fox, 1978), and labeled proteins separated from free iodide 
on Sephadex G25 equilibrated in a buffer of 0.15 M NaCI,  0.02 M Hepes, 
3 mM Ca  2+, 1 mM Mg  2+, 10 mM CHAPS, and 50 ttM NPGB.  Aliquots 
of labeled protein were immunoprecipitated with B3F12,  B6H12 or 3D9 
using 10 #g/ml of antibody, as described (Gresham et al., 1989). Superna- 
tants of these immunoprecipitations were then reprecipitated with 7G2 (10 
#g/ml), followed by anti-mouse Ig Sepharose (Cooper Biomedical, Inc., 
Malvern, PA). After thorough washing,  precipitated proteins were eluted 
from the anti-mouse Ig Sepharose with SDS-PAGE sample buffer and ana- 
lyzed by SDS-PAGE. 
Other Techniques 
Fluorescent flow microcytometry (Brown  and Goodwin,  1988),  Western 
blotting (Brown and Goodwin,  1988),  and Staphylococcus V8 protease 
cleavage and peptide analysis (Cleveland  et al.,  1977) were all performed 
as previously described. SDS-PAGE was performed essentially as described 
(Maizel, 1971). Some samples were prepared by heating at 60°C for 15 min 
rather than at  100°C  or  5  min,  because  100*C  incubation resulted in 
significant  aggregation  of the purified  protein (see Results). 
Results 
Purification of  lAP 
Initially, we purified antigen from placental membranes by 
wheat germ agglutinin chromatography, removal of nonspe- 
cifically adsorbing proteins on an irrelevant affinity column, 
and two rounds of B6H12 antibody-Sepharose affinity chro- 
matography. SDS-PAGE of the resultant protein revealed a 
major diffuse band at Mr "~50,000 (Fig.  2).  On reduction 
with DTT, it migrated at slightly higher apparent molecular 
mass. There was a minor band at 100 kD. Several pieces of 
data suggested that the 100-kD band represented a dimer of 
the 50-kD protein. Within a single purified preparation, the 
ratio of higher band to lower band increased as more antigen 
was loaded onto the gel, and higher apparent molecular mass 
bands were especially marked if the sample was heated at 
100°C, rather than at 60°C. Slower migrating bands appeared 
on reduction and were consistent in apparent molecular mass 
with still higher order aggregates (Fig. 2). In addition, SDS- 
PAGE of  the B6H12 antigen followed  by electro-elution of  the 
lower band and reelectrophoresis still revealed two bands in 
approximately the same ratio as the original material (Fig. 
2). Reduction and alkylation of antigen before electrophore- 
sis did not decrease the amount of the higher band; in fact, 
reduction tended to increase the aggregation (Fig. 2). Two- 
dimensional nonreduced, reduced SDS-PAGE showed that 
aggregation of the lower band during electrophoresis in the 
second dimenbion led to a band at exactly the apparent mo- 
lecular mass of the higher band (not shown). The amino ter- 
mini of both the higher and the lower bands were blocked, 
precluding direct determination of amino-terminal sequence. 
Finally, both bands were recognized by B6H12 antibody on 
Western blot. Based on all the evidence, we concluded that 
the higher apparent molecular mass band represented an ag- 
gregate of the lower, which arose at least in part during sam- 
ple preparation for SDS-PAGE and during electrophoresis. 
Thus, the apparent molecular mass of the monomer LAP on 
SDS-PAGE is ~50,000 and the antigen increases slightly in 
Mr to '~55,000 upon reduction. 
Purified IAP was cleaved with trypsin and several major 
peptide peaks were partially sequenced (Table I).  The se- 
quences were not contained within any proteins in the NBRF 
data base and specifically were different from any peptides 
within the deduced protein sequences of integrin chains t~v, 
gpHb, Ors, ix,,, ix2, txu, tx,,, O~L, ]~1, /~2, and ~3" 
Characterization  of  Monoclonal and Polyclonal 
Antibodies to Purij~d lAP 
Because the antigen that we purified with B6HI2, the anti- 
body that inhibited RGD-stimulated ingestion, was appar- 
ently not an integrin, we needed to explore further its rela- 
tionship  to  RGD-stimulated  phagocytosis.  We considered 
the possibility that B6H12 antibody cross-reacted with a cell 
surface molecule involved in RGD binding that was other- 
wise unrelated to the antigen purified by affinity chromatog- 
raphy.  To examine this  possibility,  monoclonal and  poly- 
clonal antibodies were prepared using the purified placental 
protein as immunogen. These antibodies initially were ex- 
amined for their ability to compete with B6H12 for binding 
in an ELISA. We examined six independently selected mAbs 
as well as a  polyclonal antiserum.  Of the six mAbs,  four 
competed with B6H12 for binding by ELISA, suggesting that 
Table L Tryptic Peptide Sequences  from lAP 
No.  Sequence 
1  IQPSH 
2  LVPTNF 
3  AVSHTG 
4  VPTDFSSAK 
5  SAVSVTGXYTEVTXL 
6  IYTFDGAL 
7  AVPQLITSN 
8  YFDVTE 
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COMPETING ANTIBODY  CONC. 
Figure  3.  Competitive  inhibition  of B6H12 binding  by  mAbs 
directed against lAP. Biotinylated B6H12 (200 ng/well) was in- 
cubated on ELISA plates coated with 100 ng of  purified 50-kD pro- 
tein with 100 #1 of various dilutions of tissue culture supernatants 
containing mAbs that recognize IAP. After 2 h incubation, B6HI2 
binding was quantitated using avidin-peroxidase, followed  by o-phe- 
nylenediamine substrate. Data are plotted as optical density devel- 
oped in each well versus competing antibody concentration (anti- 
body concentration  =  81 corresponds to undiluted tissue culture 
supernatant). 2Ell and 2D3 did not inhibit B6H12 binding, where- 
as IF'/, 2B'/, 3E9, and 3G3 did. Representative of two experiments. 
this  was  an  immunodominant  epitope  (Fig.  3).  The  two 
which did not compete (2D3 and 2El 1) both recognized the 
50-kD protein on Western blot (Fig. 4), demonstrating that 
their reactivity in the ELISA was with the purified antigen 
and not with a trace contaminant. 
lAP Is Expressed on Many Cell ~pes 
Next, we undertook a survey of antigen expression on vari- 
ous cell types. We found that B6HI2 bound to all hematopoi- 
eric  cells,  including  erythrocytes, lyrnphocytes, platelets, 
and monocytes (Fig. 5) as well as neutrophils (Gresham et 
al.,  1989), and to the promonocytic and promyeloeytic cell 
lines U937 and HL60 (not shown). The polyclonal antibody 
also recognized each of these cells (data not shown). 2Ell 
and 2D3, the mAbs that did not crossreact with B6H12 by 
ELISA, also recognized all cell types tested (Fig. 6). Thus, 
at least two, and probably three, distinct epitopes of the 50- 
kD antigen were broadly and strongly displayed on all hema- 
topoietic cell types and at least two cell lines. This suggested 
that the antigen purified by B6H12 affinity chromatography 
is expressed at the plasma membrane. 
Next, platelets were surface labeled with t2sI,  solubilized, 
and subjected to affinity chromatography on B6H12 Sepha- 
rose as described in Materials and Methods for LAP purifi- 
cation. Under these conditions, a prominent 50-kD band was 
seen (Fig. 7). This also suggests that LAP can be expressed 
on the plasma membrane. Despite its abundance as deter- 
mined by immunofluorescence and antibody binding,  LAP 
labels very poorly with a  variety of iodination techniques. 
For example, on U937 cells, which express •100,000  B6H12 
binding sites (Brown, E., unpublished data), <I).01% of pro- 
tein bound 12q (as judged by TCA precipitability after solu- 
bilization)  was  specifically bound  to  the  B6H12  affinity 
column. Thus, far, we have found platelets, from which we 
recover 20-60  x  103 LAP molecules/cell by affinity chro- 
matography, to be the cell on which IAP labels best by sur- 
face labeling techniques. 
To test whether the membrane molecule recognized by 
B6H12  was  similar  in  all  cells,  antigen  was  purified by 
B6H12 affinity chromatography from platelets and erythro- 
cytes. The purified antigen from both cell types displayed a 
band pattern on silver strain similar to that of the placental 
antigen, showing a major silver-stained band at 50 kD, with 
a minor band at 100 kD (Fig. 8 A). The same 50-kD band 
was  seen after B6H12  affinity chromatography of lysates 
from  the  monoeytoid cell  line  U937  and  from the  my- 
elomonocytic cell  line  HL60  as  well  (data  not  shown). 
Staphylococcus  V8  protease  digests  of  erythrocyte  and 
placental 50-kD antigen showed similar gel patterns (Fig. 8 
B). Thus we concluded that LAP, the 50-kD protein recog- 
nized by B6H12, is a widely distributed molecule or closely 
related family of molecules, which can be expressed at the 
plasma membrane on a variety of hematopoietic cells. 
Physical Association between lAP and B3 lntegrins 
We considered the possibility that LAP itself bound to the 
RGD  sequence.  This  might  have  been  why  it  originally 
bound  to  KYAVTGRGDS-Sepharose  (Gresham  et  al., 
1989). Therefore, purified, radiolabeled LAP was incubated 
with  KYAVTGRGDS-Sepharose  (Brown  and  Goodwin, 
1988). Less than 0.5% of the LAP bound to and eluted from 
the column.  As  a  control, placental  vitronectin receptor 
(VnR) was purified on 7G2 (anti-~3)  Sepharose by a  pro- 
tocol identical to the  one used to purify LAP on B6H12 
Sepharose.  20%  of this  radiolabeled vitronectin receptor 
bound to and eluted from the KYAVTGRGDS-Sepharose. 
Thus, affinity-purified LAP did not itself recognize the RGD 
sequence. 
Next, we considered the possibility that B6H12 recognized 
Figure 4. Western blot of placen- 
tal IAP. Solubllized  placental pro- 
teins were precleared  on 7-IFN 
sepharose and then IAP purified 
by  affinity  chromatography  on 
B6H12 Sepharose. Purified anti- 
gen was incubated  at 60°C in sam- 
ple buffer  and then eleetrophoresed 
in 7.5% SDS-PAGE. Various lanes were subjected to Western blot- 
ting with 3F12 (=B3F12), anti-c~v; 2D3, 2El1, and B6H12, anti- 
IAP;  3D9, anti-CR1; and 7(32, anti-/33. The anti-IAP antibodies 
were used at 1/xg/ml, the others at 10 ttg/ml. Blots were developed 
by subsequent incubation with rabbit anti-mouse Ig and 12SI-pro- 
tein A. The anti-IAP antibodies recognize a 50-kD protein; 7G2 
faintly recognizes a 90-kD protein; the 3F12 and 3139 lanes are 
blank. 
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Figure 5. Fluorescent analysis of B6HI2 binding to hematopoietic 
cells.  B6H12 binding  to monocytes,  lymphocytes,  platelets,  and 
erythrocytes was tested by fluorescent flow cytometry, as described 
(Brown and Goodwin,  1988). Fluorescence  distribution  for each 
cell type after incubation with an isotype control antibody is shown 
in the solid lines; fluorescence distribution after B6H12 staining is 
shown with the stippled lines. All cell types tested are reactive, as 
are PMN. 
VnR in addition to the 50-kD protein. To assess this, two ex- 
periments were performed.  First,  aliquots  of radiolabeled 
placental  proteins  were  incubated  with  B3F12  (anti-o~v), 
B6H12 or an irrelevant (3D9, anti-CR1) antibody. The pre- 
cleared lysates were then precipitated with the anti-/33 mAb, 
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Figure 6. Fluorescent  analysis of anti-IAP mAb binding. Fluores- 
cence distribution of cells after incubation with control mAb (solid 
lines), mAb 2D3 (stippled lines), or mAb 2Ell (hatched lines) is 
shown for monoeytes, lymphoeytes, platelets, and erythrocytes. All 
cell types shown stain with these two mAbs, which do not recognize 
the same epitope as B6H12. PMN, U937, and HL60 cells are also 
stained with these antibodies.  Methods as in Fig. 4. 
Figure 7. Immunoaflinity iso- 
lation of IAP from surface io- 
dinated platelets. Intact plate- 
lets were iodinated as described 
in Materials and Methods, sol- 
ubilized in 100 mM octylglu- 
coside, and incubated with ei- 
ther B6H12-Sepharose, or 3139 
(arai-CR1 [tYShea et al., 1985])- 
Sepharose as a control.  Anti- 
body-Sepharose columns were 
then washed and eluted as de- 
scribed for the purification of 
IAP. Eluates from 3D9-Seph- 
arose  (lane  1)  and  B6HI2- 
Sepharose (lane 2) were incu- 
bated with SDS-PAGE sample 
buffer at 60°C before electro- 
phoresis and autoradiography. A broad band at 50 kD is present in 
the eluate from B6H12-Sepharose, consistent with the pattern seen 
on silver stain of purified material  (see Fig. 2). 
7G2. As shown in Fig. 9 A, while preincubation with B3F12 
cleared most of the VnR from the solubilized placental pro- 
tein mixture, preincubation with B6H12 had no effect on sub- 
sequent precipitation of VnR by 7G2. Thus B6H12 did not 
immunoprecipitate  VnR  under  these  conditions.  Second, 
placental VnR was purified by affinity chromatography on 
7G2 Sepharose and subjected to Western blotting with B6H12 
and several other mAbs that recognize the 50-kD antigen. 
None  recognize  VnR  by  Western  blot  (Fig.  9  B).  Thus, 
B6H12, which was raised against a placental antigen purified 
on RGD-Sepharose did not bind VnR directly, nor did its ap- 
parent antigen bind to the RGD sequence. 
For these reasons, we considered the hypothesis that the 
50-kD protein could,  under  some circumstances,  interact 
with an RGD-binding integrin. Immunoprecipitation of sur- 
face labeled PMN with B6H12 showed a heterodimer consis- 
tent with an integrin structure (Gresham et al.,  1989). Fur- 
thermore,  some binding of 7G2 (anti-t3) to a  90-kD band 
was observed in Western blots of lAP purified from placenta 
by B6H12 affinity chromatography (Fig. 4). These data sug- 
gested that lAP might be physically associated with PMN 
and  placental  integrins.  To  obtain  further  evidence  for  a 
physical association between IAP and integrins, surface iodi- 
nated platelets were solubilized in a low concentration of Tri- 
ton X-100 and immunoprecipitated with B6H12, 2D3,  and 
the polyclonal anti-lAP antibody. Immunoprecipitation with 
all three anti-lAP antibodies revealed two bands not present 
in the control, at 90 and  175 kD, in addition to the diffuse 
band at 50-kD, which is the B6H12 antigen (Fig.  10).  The 
two higher  apparent molecular mass bands  are consistent 
with the noncovalent heterodimeric structure of an integrin. 
2D3 does not compete with B6H12 for binding to lAP (see 
Fig. 3); thus antibodies against two different epitopes of lAP 
coprecipitate the high apparent molecular mass bands.  To 
test the hypothesis that these bands are an integrin, platelet 
antigen  isolated on B6H12  was  subjected  to Western  blot 
with 7G2 (Fig.  11 A). 7G2 recognized a 90-kD band in this 
preparation.  A  similar experiment performed by isolating 
lAP on 2D3 Sepharose also revealed a coprecipitating 90-kD 
band  that  was  not  seen  when  platelet  lysates  were chro- 
matographed on W6/32 (anti-HLA Class I) Sepharose (Fig. 
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antigen from platelets and erythro- 
cytes. The 50-kD antigen was pu- 
rified from platelets  and erythro- 
cytes essentially  as described for 
placenta in Fig.  2, and prepared 
for SDS-PAGE  by incubation in 
sample buffer at 100°C, and elec- 
trophoresed  on  5-10%  gradient 
gels,  followed  by silver  staining 
(A). Purified antigen was radiola- 
beled, digested with Staphylococ- 
cus aureus V8 protease,  and run 
on 15% SDS-PAGE (B). Peptides 
were detected by autoradiography. 
Purified  antigens  from platelets 
and  erythroeytes appear  similar 
in relative molecular mass and in 
proteolytic fragments and are simi- 
lar to placental antigen in relative 
molecular mass and potential  to 
aggregate  on heating. 
11 B). Thus, the 90-kD band seen in immunoprecipitations 
is recognized by 7G2 on Western blots and thus is gplIIa or 
an  immunologically  related  protein.  The  50-kD  band 
purified on 2D3 Sepharose is recognized by B6H12 (Fig.  11 
B) and thus is lAP.  These data show that/33  integrins can 
be copurified and coprecipitated with lAP. 
To determine  whether this association between IAP and 
~3 integrins was a  general phenomenon, lAP was partially 
purified from various cells or tissues by affinity chromatog- 
raphy of octylglucoside lysates on B6H12 Sepharose.  The 
eluted  proteins  were  used  in  a  Western  blot  with  either 
B6H12 antibody (Fig.  12 A) or 7G2 antibody (Fig.  12 B). 
Figure 9. Anti-IAP antibodies  do 
not recognize VnR. (A) 125I-labeled 
placental lysate was precleared by 
immunoprecipitation with: irrel- 
evant antibody 3139 anti CR-1 (lane 
1 ); anti-uv antibody B3F12 (lane 
2); or anti-IAP B6H12 (lane 3), 
as described in Materials and Meth- 
ods.  Supernatants  were then im- 
munoprecipitated with 7(32 (anti- 
/~3).  Whereas  B3F12  removed 
most  of  the  7G2-precipitatable 
material  from placenta, preclear- 
ance with B6H12 had no effect on 
subsequent  VnR immunoprecipi- 
tation.  (B) VnR from unlabeled 
placental  lysates  was  affinity 
purified  with  7G2-Sepharose  as 
described in Materials  and Meth- 
ods.  Elnted  proteins  were  then 
prepared for SDS-PAGE at 60°C, 
electrophoresed,  and  Western 
blotted with 3F12 (B3FI2), anti- 
cry; 7G2, anti-/~3, and four anti-LAP antibodies,  2D3, 2El1, 3Ell, and B6H12.  The faint staining  of a "~150-kD c~v band by 3F12, a poor 
reagent  for Western  blotting,  is barely visible.  None of the anti-IAP mAbs recognize VnR by Western  blotting. 
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from platelets. Platelets were sur- 
face radiolabeled and solubilized 
in 0.2% Triton X-100-containing 
buffer. After preclearing with gel- 
atin-Sepharose, the labeled lysates 
were incubated with: lane 1, anti- 
phosphorylcholine (HYPC 1643)- 
Sepharose; lane 2, polyclonal rab- 
bit  anti-lAP  Sepharose;  lane  3, 
2D3  (anti-IAP)  Sepharose;  lane 
4,  B6H12 (anti-lAP)  Sepharose. 
Specifically  immunoprecipitated 
bands at 90 and 175 kD, in addi- 
tion to the broad band at 50 kD, 
are  seen  in  the  lanes  incubated 
with anti-lAP  antibodies. 
B6H12 recognized a  50-kD band from erythrocytes, plate- 
lets, and placenta. A weaker band was seen at -o100 kD, con- 
sistent with the dimerization seen on silver stain, since this 
preparation was incubated at 100°C before SDS-PAGE (see 
Fig.  2).  7G2, the mAb to/~3,  blotted a  copurifying 90-kD 
band from platelets and placenta, but not from erythrocytes. 
Thus, in two of the three tissues examined, the 50-kD B6H12 
antigen was associated with a 90-kD chain that has antigenic 
similarity to integrin/33. 
Figure 1L  Western  blot of platelet  proteins  binding  to anti-lAP 
affinity columns. Platelets were solubilized in 100 mM octylgluco- 
side and chromatographed  on B6H12 Sepharose (A), or 2D3 (anti- 
IAP) or W6/32 (anti-HLA Class I) Sepharose (B). Eluted proteins 
were incubated at 60°C and electrophoresed  on 7.5% SDS-PAGE. 
In A, 7(32 (anti-/33) is shown to recognize a 90-kD band that is not 
recognized by the irrelevant 3139 (anti-CR1) antibody. In B, lanes 
I and 3 are Western blots of proteins eluted from 2D3 Sepharose; 
lanes  2  and 4  are Western  blots  of proteins  eluted  from W6/32 
Sepharose. lanes I  and 2 have been developed with 7132 (anti-fl3) 
antibody; lanes 3 and 4 have been developed with B6H12 antibody. 
7(32 recognizes a 90-kd band in the 2D3 eluate which is not present 
in the W6/32 eluate. B6H12 recognizes a 50-kd protein in the 2D3 
eluate that is similarly not purified on the anti-HLA class I column. 
Figure 12. Western blotting of afffinity-purified  protein from plate- 
lets,  placenta,  and  erythrocytes.  Detergent-solubilized  platelets, 
placenta,  and erythrocytes were incubated with B6H12-Sepharose, 
and the column washed and eluted as described  in Materials  and 
Methods. Platelet lysate was also incubated with Sepharose bearing 
the anti-MHC class I mAb W6/32 as a control. 2 #g of each eluate 
was incubated at 100°C with SDS-PAGE sample buffer, electropho- 
resed on 5-10 % gradient gels, and transferred to Immobilon  (Milli- 
pore Corp., Bedford, MA) membranes. In A, the blots were probed 
with B6H12 antibody and in B with 7G2 antibody. Lane I, W6/32 
eluate from platelets; lane 2, B6HI2 eluate from platelets; lane 3, 
B6H12 eluate from placenta;  lane 4, B6H12 eluate from erythro- 
cytes.  A 90-kD band recognized by 7G2 coelutes with IAP from 
platelets and placenta, but not erythrocytes. The 200-kD band pres- 
ent in lane 3 in A and B is nonspecific, since it can be detected even 
in the absence of mAb incubation (for comparison, see Figs. 4 and 
11 A). 
Antibodies to lAP Inhibit LRI-dependent Stimulation 
of Phagocytosis 
To test whether lAP was involved in LRI-dependent stimula- 
tion of ingestion, all six new mAb were tested for their ability 
to inhibit RGD-stimulated phagocytosis by PMN. Three of 
the  antibodies  which  inhibited  B6H12  binding  inhibited 
branched RGD enhancement of EIgG ingestion by PMN; in- 
terestingly,  one (3G3) did  not  (Fig.  13).  Importantly, one 
(2Ell)  of the two antibodies  which did  not compete with 
B6H12  also  inhibited  RGD-dependent  phagocytosis;  the 
other (2D3) did not (Fig. 13). The polyclonal antiserum also 
inhibited RGD-stimulated ingestion. None of these antibodies, 
including  B6H12,  affected unstimulated  or phorbol ester- 
stimulated EIgG ingestion by PMN, showing that these anti- 
bodies were not generally toxic to the phagocytic process. 
Thus,  antibodies  directed  against two distinct  epitopes of 
lAP could specifically inhibit RGD-stimulated phagocytosis. 
This was evidence against the possibility that the effects of 
B6H12  on phagocytosis enhancement represented an inci- 
dental cross-reactivity of the antibody.  Thus,  RGD-stimu- 
lated ingestion by PMN is affected by antibodies to lAP. 
Our previous data showed that RGD-dependent phagocy- 
tosis was mediated by an integrin,  the  LRI.  Studies  with 
polyclonal antibodies suggested that LRI, like the copurify- 
ing integrins from platelets and placenta, was related to the 
/33 integrin family (Gresham et al.,  1989).  To confirm this, 
we used the  anti-B3  mAb 7G2 which inhibits VnR (Otv/33)- 
dependent ingestion (Savill et al., 1990). Consistent with the 
polyclonal data,  7G2  inhibited  Fn-stimulated  ingestion by 
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Figure 13. Inhibition of RGD-stimulated phagocytosis by anti-IAP 
antibodies. Branched RGD peptide was used to stimulate ingestion 
of EIgG and antibodies were tested for inhibition of stimulation as 
described (Gresham et al., 1989). 100,000 PMN were incubated 
with 1:20 dilutions of serum-free tissue culture supernatants or 1.65 
#g of purified polyclonal antibody in the presence of 5,000 U of 
catalase for 15 min at room temperature before addition of EIgG. 
Unstimulated ingestion is shown in the open bars; stimulated inges- 
tion in the hatched bars. Branched peptide led to a threefold in- 
crease in phagocytosis (buffer columns), mAb 3E9, 2El 1, 2B7, 
and  1F7,  and  the polyclonal antibody all prevented  the RGD- 
dependent enhancement of ingestion without affecting unstimulated 
ingestion. 2D3, which did not compete with B6H12 for binding to 
IAP (see Fig. 3) and 3G3, which did, affected neither unstimulated 
or stimulated ingestion. Data are the mean + SEM of three to four 
determinations for each antibody. 
PMN (Fig. 14). This inhibition was not dependent on recog- 
nition of VnR by 7(32,  since PMN have no detectable VnR 
(Gresham et al., 1989). Thus antibodies to both/~ and lAP 
inhibit RGD-stimulated ingestion by PMN, suggesting that 
there is a functional association between LRI and IAP. 
To determine whether the same functional association ex- 
ists on monocytes, we tested the ability of B6H12 antibody 
to  inhibit  complement  receptor-mediated  phagocytosis 
stimulated by fibronectin. As shown in Fig. 15, both B6H12 
and 7G2 inhibited monocyte phagocytosis of C3b opsonized 
erythrocytes. B3F12,  (anti-o~0  which  inhibits VnR-depen- 
dent ingestion by macrophages (Savill et al.,  1990), neither 
bound to uncultured monocytes (data not shown),  nor in- 
hibited fibronectin stimulation of phagocytosis. Thus both 
B6H12 and 7G2 were able to inhibit fibronectin-stimulated 
phagocytosis by both PMN and monocytes, mediated by ei- 
ther IgG Fc or complement receptors. These data demon- 
strate that both LRI and IAP are involved in RGD-dependent 
stimulation of phagocytosis for PMN and monocytes. 
Discussion 
Previously,  we  produced  B6H12,  an  mAb  that  inhibited 
RGD-stimulated ingestion by PMN, and presented evidence 
that the stimulation was dependent on RGD interaction with 
a cell surface integrin (Gresham et al., 1989). In the current 
study, we have shown that the antibody also inhibits fibronec- 
tin  stimulated  ingestion by monocytes,  suggesting  that  it 
recognizes a molecule involved generally in RGD effects on 
phagocytosis. We have now purified the antigen recognized 
by B6H12. It is a 50-kD protein, originally purified from 
placenta, but equivalent to a plasma membrane protein of  all 
hematopoietic cells. This protein appears not to be a proteo- 
lyric fragment of an integrin, but an independent molecule 
which coassociates with specific B3 or/~3-1ike  integrins on 
PMN,  platelets,  and  placenta.  For this  reason,  we  have 
called it lAP. Limited sequencing of tryptic peptides from 
lAP show no relationship to known integrins, and, in fact, 
show no identity to any sequences in the NBRF/PIR data 
base. This unexpected finding led us to consider the possibil- 
ity that the B6H12 antibody crossreacted on intact ceils with 
a  plasma  membrane  integrin  which  was  lost during  our 
purification procedure, or that the 50-kD molecule indepen- 
dently recognized the RGD sequence. However, B6H12 did 
not immunoprecipitate VnR or recognize it by Western blot. 
Although we cannot be certain it was functionally active, 
affinity-purified  lAP did not bind to an RGD peptide column. 
Several monoclonal and polyclonal antibodies against purified 
lAP stained the plasma membranes of hematopoietic cells, 
and antibodies against two distinct epitopes inhibited RGD- 
stimulated ingestion.  Initial studies with B6H12 suggested 
that there might be a physical link between lAP, its antigen, 
and a/~3  integrin.  B6H12 coprecipitated additional higher 
apparent molecular mass chains with lAP, and the 90-kD 
band was recognized by the B3-specific mAb 7G2. Similar 
studies were performed with 2D3, an mAb prepared against 
IAP, but that recognized a distinct epitope from B6H12 and 
which had no effect on RGD-stimulated phagocytosis. Im- 
munoprecipitation of surface radiolabeled platelets with 2D3 
coprecipitated similar high apparent molecular mass bands 
as B6H12, and the 90-kD band was again recognized by 7G2 
on Western blot. These data greatly decreased the likelihood 
that the original observations with B6H12 resulted from a 
fortuitous crossreactivity, and we have concluded that lAP 
indeed is involved in RGD-stimulated ingestion. At this point 
we are not certain of the stoichiometry or the functional 
significance of the apparent physical association of lAP with 
B3 or B3-1ike integrins.  IAP itself labels very poorly and 
variably on intact cells with  1251, by a  variety of labeling 
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Figure 14. Effect of anti-/33 mAb 7(32 on Fn-stimulated ingestion 
by PMN. The effect of Fn on phagocytosis of EIgG by PMN in 
the presence of 7(32 (a) or the anti-t~v  antibody B3F12 (e) as a 
control was assessed as described in Fig.  13. 100,000 PMN were 
incubated with 0.4/~g of purified 7G2 or B3F12 in the presence of 
5,000 U catalase for I h at 4°C before addition of EIgG and warm- 
ing to 37°C. Fn induced a fourfold increase in phagocytosis in the 
presence of  B3FI2.7(32 almost completely inhibited enhancement. 
Data are representative of two experiments. 
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Figure 15. Effect  of B6H12 and 7G2 on fibronectin stimulation of 
monocyte CRl-mediated phagoeytosis. Fres.hly elutriated mono- 
cytes (90-98 % esterase positive) were adhered to LabTek  chambers 
and incubated with 10/zg/ml  mAb or with buffer for 15 min at room 
temperature before warming to 37°C with addition of EC3b and 40 
#g/ml  fibronectin. Phagocytosis in antibody-containing wells is 
compared with buffer as percent control  =  PI (mAb well)/PI 
(buffer well). 7(32 and B6H12 both inhibit fibronectin-stimulated, 
CRl-mediated ingestion, whereas B3F12 (anti-txv) does not. Data 
represent mean +  SEM of six experiments. 
techniques. This may explain why it was not discerned in our 
original immunoprecipitations from PMN (Gresham et al., 
1989). 
IAP does not associate with aU integrins. In preliminary 
work we have shown that B6H12  antibody does not affect 
/32-dependent  functions on  PMN,  such as phorbol  ester- 
stimulated phagoeytosis (Graham et al.,  1989),  or PMN 
adhesion to protein-coated plastic, or VLA dependent adhe- 
sion to fibronectin or laminin. We considered the possibility 
that LAP is a fragment of an a  chain that associates with/33. 
This hypothesis would require that LAP be part of a new a 
chain, since neither gpllb nor otv is expressed on PMN or 
uncultured monocytes nor has a known 50-kD cleavage frag- 
ment. Moreover, sequence data from tryptic peptides of  LAP 
do not contain gpllb or otv sequences.  The distribution of 
the 50-kD antigen does not correspond to that of/~3, since 
it is present on erythrocytes, a cell type which contains no 
/33  integrin.  It  might  be  possible  that  the  putative  un- 
described ot chain could associate with two different/~ chains 
to explain its broad cell distribution (Cheresh et al., 1989). 
Again,  the  strong  expression  of IAP  on  erythrocytes is 
against this hypothesis, since erythrocytes express no known 
integrin/3 chains. It is most likely that the antigen recognized 
by B6H12  is a membrane molecule that is associated with 
integrin function on some cells, but that is expressed in- 
dependently of the integrins themselves. At this point, we 
cannot determine whether the specificity of the association 
between LAP and LRI is related to the integrin a  or/~ chain. 
It is possible that LAP interacts with the LRI o~ or possibly 
c~v. However,  an alternative hypothesis is that the/3rlike 
molecule associated with LAP is not exactly equivalent to 
gpRIa. Two forms of intracytoplasmic tail of/~3 have been 
identified, generated by alternative splicing of mRNA (van 
Kuppevelt et al., 1989). IflAP is associated specifically with 
an integrin/~ chain, it may be with only one of these or other 
forms of integrin/3 cross-reactive with/33. 
What role does LAP play in RGD-stimulated ingestion? 
One possibility is that is is merely closely associated with 
the integrin receptor and that mAbs to it inhibit RGD ligand 
binding by steric blockade; mAbs that do not inhibit stimu- 
lated phagocytosis might be direct at epitopes of IAP distant 
from its site of association with integrins. Against this "pas- 
sive bystander" hypothesis is the fact that mAb 3G3 binds to 
an epitope very close to B6H12, since it inhibits binding in 
the ELISA, but does not affect RGD-stimulated ingestion. 
Moreover,  both  B6H12  and  2Ell,  which  inhibit  RGD- 
stimulated ingestion at low concentration, enhance ingestion 
on  their  own  at  higher  concentrations  (Gresham  et  al., 
1989).  Anti-IAP mAbs that do not inhibit ingestion do not 
have this effect. This would suggest that sufficient antibody 
binding induces the "activated" state of the integrin. This 
would be hard to explain by simple steric inhibition of ligand 
binding and implies that there is a  functionally important 
relationship between LAP and the RGD-binding integrin. 
A more intriguing possibility is that LAP is a part of the 
signal transduction mechanism by which RGD ligands com- 
municate the signal for enhanced ingestion to the cell interior. 
If LAP selectively associated with only some integrins, its in- 
volvement in  signal transduction may be associated only 
with very specific functions. There is now reasonable evi- 
dence that at least some integrins transduce signals that alter 
cell behavior (van Noesel et al., 1988; Gresham et al., 1989; 
Groux, et al.,  1989;  Wacholtz et al.,  1989;  Werb et al., 
1989). In many cases, however, this concept has been difficult 
to investigate, since ligand binding by integfins often leads 
to cell attachment and spreading on surfaces, an effect that 
in itself may markedly alter cell responses. Our system is 
particularly amenable to the  study of signal transduction 
through integrins, since the LRI on phagocytes regulates in- 
gestion even when it is occupied by a soluble ligand and the 
phagocytes are nonadberent.  Thus,  signal transduction in 
this system can be completely separated from any effects of 
cell adhesion and spreading on two dimensional surfaces. If 
this is the role for LAP, its signal transducing role is inti- 
mately involved with ligand binding, since B6H12 inhibits 
RGD binding as well as enhanced phagocytosis. This would 
suggest that antibodies which inhibit RGD-stimulated pha- 
gocytosis may do so by stabilizing a  conformation of the 
LRI-LAP complex with decreased affinity for ligand. Sufficient 
aggregation of receptors in this conformation by high con- 
centrations of antibody might be enough to induce signal 
transduction for increased phagocytosis. Finally, it is intrig- 
uing to speculate that since LAP is expressed on cells inde- 
pendent of  integrin expression (e.g., on erythrocytes), it may 
represent  a  molecule involved in  signal  transduction for 
other receptors as well. The 3, chain of the high affinity IgE 
receptor recently has been shown also to associate with cer- 
tain IgG receptors and participate in their expression and 
function (Ra et al.,  1989;  Hibbs et al.,  1989). 
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